The global demand for Induced Pluripotent Stem Cells Production Market is presumed to reach the market size of nearly USD 2,638.4 BN by 2030 from USD 1,274.71 BN in 2022 with a CAGR of 9.31% under the study period 2023 - 2030.
Induced pluripotent stem cells are cells derived from adult somatic cells and then further reprogrammed to obtain the pluripotency that of ESCs (Embryonic Stem Cells). These iPSCs (induced pluripotent stem cells) are a morally simple substitute for ESC-based research. The creation of ESCs involves killing an embryo at the blastocyte stage, which has generated the most ethical controversy. In contrast, induced pluripotent stem cells, which merely involve the genetic reprogramming of somatic cells, have addressed the moral dilemma of killing human embryos in research.
Market Dynamics
The induced pluripotent stem cells market is expanding rapidly due to the possibility of stem cell-based therapeutics, rising research funding, the rising prevalence of cancer, and the numerous benefits of induced pluripotent stem cells (iPSCs) over embryonic stem cells (ESCs). IPSC-based research was further helped by the rise in research efforts during the COVID-19 pandemic. The need for iPSCs as research tools has also been augmented by scientists' ongoing efforts to discover novel medications and treatments to manage the SARS-CoV-2 illness. Additionally, because induced pluripotent stem cells may create organoids or organ models that are physiologically identical to real organs, they can be utilized to study the pathophysiology of viral infection in humans.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of induced pluripotent stem cells production. The growth and trends of induced pluripotent stem cells production industry provide a holistic approach to this study.
Market Segmentation
This section of the induced pluripotent stem cells production market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Process
- Manual IPSC Production Process
- Automated IPSC Production Process
By Workflow
- Reprogramming
- Cell Culture
- Cell Characterization / Analysis
- Engineering
- Others
By Product
- Instruments/ Devices
- Automated Platforms
- Consumables & Kits (Media, Kits, Others)
- Services
By Application
- Drug Development & Discovery
- Regenerative Medicine
- Toxicology Studies
- Others
By End-User
- Research & Academic Institutes
- Biotechnology & Pharmaceutical Companies
- Hospitals & Clinics
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Induced Pluripotent Stem Cells Production market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Induced Pluripotent Stem Cells Production Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the induced pluripotent stem cells production market include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Reprocell Inc., Merck KGaA, Fate Therapeutics, Thermo Fisher Scientific Inc., Applied StemCells Inc., Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.